1-Methyladenosine
(Synonyms: 1-甲基腺苷) 目录号 : GC334631-甲基腺苷是一种在1 位带有甲基取代基的甲基腺苷。它具有作为人体代谢物的作用,在功能上与腺苷有关
Cas No.:15763-06-1
Sample solution is provided at 25 µL, 10mM.
1-Methyladenosine is a modified nucleoside generated by the processing of tRNA by methyltransferases.1,2,3 The urinary excretion of 1-methyladenosine is elevated in several forms of cancer, supporting its use as a biomarker in early detection.4,5,6 It can also be monitored in serum.7 Urinary levels of 1-methyladenosine also increase during active rheumatoid arthritis.8
1.Munns, T.W., and Sims, H.F.Methylation and processing of transfer ribonucleic acid in mammalian and bacterial cellsJ. Biol. Chem.250(6)2143-2149(1975) 2.Vold, B.Modified nucleosides of Bacillus subtilis transfer ribonucleic acidsJ. Bacteriol.127(1)258-267(1976) 3.Chujo, T., and Suzuki, T.Trmt61B is a methyltransferase responsible for 1-methyladenosine at position 58 of human mitochondrial tRNAsRNA18(12)2269-2276(2012) 4.Reynaud, C., Bruno, C., Boullanger, P., et al.Monitoring of urinary excretion of modified nucleosides in cancer patients using a set of six monoclonal antibodiesCancer Lett.255-262(1991) 5.Seidel, A., Brunner, S., Seidel, P., et al.Modified nucleosides: An accurate tumour marker for clinical diagnosis of cancer, early detection and therapy controlBr. J. Cancer.94(11)1726-1733(2006) 6.Hsu, W.Y., Chen, C.J., Huang, Y.C., et al.Urinary nucleosides as biomarkers of breast, colon, lung, and gastric cancer in TaiwanesePLoS One8(12)1-8(2013) 7.Chen, F., Xue, J., Zhou, L., et al.Identification of serum biomarkers of hepatocarcinoma through liquid chromatography/mass spectrometry-based metabonomic methodAnal. Bioanal. Chem.401(6)1899-1904(2011) 8.Tebib, J.G., Reynaud, C., Cedoz, J.P., et al.Relationship between urinary excretion of modified nucleosides and rheumatoid arthritis processBr. J. Rheumatol.36(9)990-995(1997)
Cas No. | 15763-06-1 | SDF | |
别名 | 1-甲基腺苷 | ||
Canonical SMILES | OC[C@@H]1[C@H]([C@H]([C@H](N2C=NC3=C2N=CN(C)C3=N)O1)O)O | ||
分子式 | C11H15N5O4 | 分子量 | 281.27 |
溶解度 | DMSO : 150 mg/mL, Water : 28.1mg/mL | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 3.5553 mL | 17.7765 mL | 35.553 mL |
5 mM | 0.7111 mL | 3.5553 mL | 7.1106 mL |
10 mM | 0.3555 mL | 1.7777 mL | 3.5553 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet